Cryogenics: Time in a Bottle
- Gillian Fletcher

- Aug 24, 2024
- 2 min read
Updated: Mar 15
Jonas Carlton wanted to stop time.
Not metaphorically. Carlton, the Conglomerate era's most celebrated and most controversial innovator, proposed a set of specifications for holding an organic life form in a perfectly static state: aging suspended, disease suspended, even the subjective experience of time passing, gone. A body preserved at the moment of entry, indefinitely, until someone decided otherwise.
The someone deciding otherwise is where it gets interesting.
The Conglomerate labeled Carlton as Subject Number One, a title that tells you everything about the kind of man they painted him to be. He threw the challenge open to the scientific community across the territory, crowd-sourcing the components of his design in the belief that collective brilliance would realize what even he could not achieve alone. It was, by any measure, a visionary idea.
He never saw it completed.

The official record describes Carlton as having failed to realize his own specifications. What followed was the Conglomerate's Assumption of his laboratory, and shortly after, the first known cryogenic units came into existence. Whether Carlton's work was unfinished or simply reassigned depends on who you ask and how much you trust the Conglomerate's version of its own history.
Given everything else we know about systemic control inside Souvern Novarica, the timing is worth noting.
Today, cryogenics is among the most heavily regulated technologies in the Conglomerate. Steep registration fees, routine inspections, and a bureaucratic apparatus that ensures most citizens only encounter cryo under extreme circumstances. The raw potential of the technology is not lost on the Board of Directors. A population that can be suspended, preserved, and reactivated on someone else's timeline is not a free one.
Carlton built the specifications for a revolution. The Conglomerate built a cage.







Comments